Dr Laura Riggall is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She obtained an MRes and PhD in Medical Imaging (Neuroscience) at University College London’s EPSRC CDT in Medical Imaging and the Francis Crick Institute. Her research focused on using magnetic resonance imaging (MRI) to investigate metabolites in the brain to develop new biomarkers of Huntington's disease. Previously, she obtained an MRes in Experimental Neuroscience from Imperial College London and a BSc (Hons) in Medical Sciences (Industrial) from the University of Leeds, which included a placement year at GSK. She has now embarked on a career in intellectual property law and is a part-qualified patent attorney at Barker Brettell LLP.
The UK Government has postponed proposed updates to 40-year-old surrogacy legislation...
Almost three-quarters of UK fertility patients used a treatment 'add-on', according to the Human Fertilisation and Embryology Authority's National Patient Survey 2024...
Subtle changes in the brain can be identified decades before a diagnosis of Huntington's disease, two major new studies that shed light on what drives the disease have shown...
The High Court has held that a patent owned by uniQure for the treatment of haemophilia B is valid and was infringed by Pfizer...
A Beijing court has ruled that a woman's rights were not violated after a hospital refused to freeze her eggs because she is not married, ending a six-year legal battle...
A UK court named a sperm donor a child's legal parent, rather than the mother's wife, because the mother secretly had sexual intercourse with the donor...
A New York appeals court has concluded that the accidental destruction of embryos in storage is negligence and not medical malpractice...
The three-dimensional structure of the X chromosome and how it is silenced in female cells has been demonstrated by a new computational method...
An international study has identified a unique pair of gene variants that can cause the sudden onset of high blood pressure in pregnant women...
In-body CRISPR-Cas9 genome editing could offer an effective treatment for a rare, life-threatening genetic condition...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
